Sign Up

TRML

COM:TOURMALINEBIO

Tourmaline Bio, Inc.

  • Stock

Last Close

24.00

21/11 17:39

Market Cap

352.13M

Beta: -

Volume Today

77.41K

Avg: -

OverviewAnalysisMetricsFinancialsFilingspeopleAPIChartData
Income StatementBalance SheetCash FlowKey MetricsRatios
Quarterly
Yearly

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '21
average inventory
average payables
480.50K
-
average receivables
book value per share
-0.02
-
capex per share
0.22
-
capex to depreciation
3.91
-
capex to operating cash flow
-0.06
-
capex to revenue
cash per share
20.74
-
days of inventory on hand
days payables outstanding
113.66
-
days sales outstanding
debt to assets
1
-
debt to equity
-0.66
-
dividend yield
earnings yield
-0.00
-
enterprise value
1.66B
-
enterprise value over ebitda
-35.47
-
ev to operating cash flow
-41.58
-
ev to sales
free cash flow per share
-3.90
-
free cash flow yield
-0.03
-
graham net net
20.70
-
graham number
0.01
-
income quality
0.84
-
intangibles to total assets
0
-
interest coverage
interest debt per share
0.01
-
inventory turnover
invested capital
4.58M
-
market cap
1.66B
-
net current asset value
-226K
-
net debt to ebitda
net income per share
-0.00
-
operating cash flow per share
-3.68
-
payables turnover
3.21
-
receivables turnover
research and ddevelopement to revenue
return on tangible assets
-0.01
-
revenue per share
roe
0.00
-
roic
-621.17
-
sales general and administrative to revenue
shareholders equity per share
-0.02
-
stock based compensation to revenue
tangible asset value
-226K
-
tangible book value per share
-0.02
-
working capital
-226K
-

All numbers in (except ratios and percentages)